Researchers at National Taiwan University have developed a liver-directed IL-10 gene therapy that strengthens cancer-fighting ...
Three 2026 Breakthrough Prize winners reflect on developing Luxturna, a gene therapy that treats blindness caused by rare ...
A first-of-its-kind gene therapy that can restore hearing in children born deaf has just cleared its final hurdle—and, in a ...
The agency's decision is based on results from a clinical trial in which the treatment improved hearing in 80 percent of the ...
Investor's Business Daily on MSN
Sarepta dives; can 2026 be the reset year for its controversial gene therapy?
Sarepta stock toppled Thursday as investors digested the better-than-feared sales of its beleaguered gene therapy, Elevidys.
Kelly Anne is a deputy editor at Forbes Advisor overseeing the development of various initiatives, including newsletters, ...
Saffie Sandford was born with Leber's Congenital Amaurosis and "missed out on a lot" due to difficulties seeing in any ...
The FDA has approved Otarmeni, the first-ever gene therapy for genetic hearing loss caused by the OTOF gene, for both ...
LONDON -- A 3-year-old girl who underwent a breakthrough gene therapy treatment to treat profound hearing loss can hear on her own, two years after the treatment. Opal Sandy made history in 2023 when ...
Groundbreaking AAV-based gene therapy offers potential treatment for patients with OTOF gene-associated severe-to-profound and profound hearing lossWhite Oak, Md., April 24, 2026 (GLOBE NEWSWIRE) -- ...
Stuart Orkin and Swee Lay Thein shared a Breakthrough Prize in Life Sciences for their research on genetic causes of sickle ...
Researchers use hIL-6 protein to restore walking in paralyzed mice by promoting neural circuit plasticity rather than fiber regrowth.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results